February 24, 2021 – NACDS has announced three leadership moves to advance a pro-patient and pro-pharmacy agenda. NACDS is fully integrating its federal legislative, grassroots, political, and strategic communications functions. The Association also said it is focused on emphasizing a highly collaborative approach to strategic policy development, federal regulatory and Executive Branch advocacy, and state government affairs.
Chris Krese will serve as SVP of Congressional relations and communications and will lead a team focused on translating the pandemic’s public health lessons into legislative results.
NACDS also is aligning strategic policy development, federal regulatory and Executive Branch advocacy, and state government affairs for a “one-team” approach to advance policy priorities established by the NACDS Board of Directors.
Christie Boutte will serve as SVP of reimbursement, innovation and advocacy. Her issue portfolio will include the 340B program, pharmacy benefit manager issues, value-based modeling and quality measures. She will continue to manage directly the state government affairs team.
Kathleen Jaeger will serve as SVP of health and wellness strategy, policy, and patient advocacy. She will lead the further development and implementation of NACDS’ health and wellness strategy and policy to deliver better access to care. Jaeger will continue to serve as president of the separate NACDS Foundation which focuses on research and education in the public interest.